Alternatively, in prostate cancer cells, CAV1 interacts with LRP6 to stimulate the IGF-IR/IR/Akt/mTORC1 pathway and promote glycolysis by increasing the expression of glucose transporters and glycolytic enzymes [16]. This evidence concerns the gene LRP6 and prostate carcinoma.